LiquiDx project closing meeting in Granada
21 Oct 25
The partners of the LiquiDx project gathered on 18 September 2025 at the Biobanco del Sistema Sanitario Público de Andalucía
The partners of the LiquiDx project gathered on 18 September 2025 at the Biobanco del Sistema Sanitario Público de Andalucía
At Leitat, we held a new follow-up meeting for the NIMBI project together with our project partner, ACCIONA, at our
Cancer immunotherapy, also known as immuno-oncology, represents one of the greatest revolutions in cancer treatment in recent decades. This therapeutic
DHA (docosahexaenoic acid) is a molecule generally used for its antioxidant activity, but it is very unstable. The GiGa-3 project
El projecte va obtenir un finançament de 985.000 € per part de l’Agència Estatal d’Investigació i reuneix un consorci de
On July 8th, Valfortec’s facilities in Castellón de la Plana hosted the fourth follow-up meeting of the STACKAEM project, an
Osteoarticular osteoarthritis is a chronic degenerative disease that affects the joints, particularly in older individuals, negatively impacting their quality of
On February 14, 2025, the kick-off meeting (KOM) of the VAGINEF project took place at the Vall d’Hebron Research Institute
Predicting the effects of climate change on the crop microbiome and the cascading effects on the provision of ecosystem services
Sustainable and extrudable 3D marine analogues through the development of innovative laminar-coaxial variable geometry 3D food printing technology. Abstract:
The MANDALA project is aimed at improving the management of water quality, a resource declared at risk of global crisis.
CANTABRIA LABS y Leitat han unido fuerzas en el proyecto UPCOSMETIC. Este ambicioso proyecto tiene como objetivo principal explorar nuevas
Las alergias alimenticias son un problema de salud significativo que afecta a más de 17 millones de personas en Europa,
Las enfermedades neurológicas, en su mayoría, tienen su origen en alteraciones en la expresión génica, regulada por mecanismos epigenéticos dentro
El proyecto MEDICSEN ofrece una opción de tratamiento no invasivo para enfermedades crónicas como la diabetes y algunas enfermedades autoinmunes,
Leitat has received 404,185.00€ in funding to develop the project Strategic Participation Plan in Horizon Europe 2024-2025 (PEP-HEU-2025), under the
Phone. (+34) 937 882 300
